Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1156 of 1,261
  1. US 6720355

    Sodium dodecyl sulfate compositions for inactivating prions

    The Regents of the University of California Β· Granted Apr 13, 2004 Β· Expires Apr 8, 2024

    expired
  2. US 6716877

    Method to treat chronic heart failure and/or elevated cholesterol levels

    Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  3. US 6717030

    Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

    The Regents of the University of California Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  4. US 6716863

    Heterocyclic compounds their production and use

    Takeda Chemical Industries Ltd. Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  5. US 6716860

    Azo amino acids derivatives

    Vertex Pharmaceuticals Incorporated Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  6. US 6716607

    Chicken interferon gene and novel recombinant DNA

    UNIVERSITY OF CONNECTICUT Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  7. US 6716450

    Enhancing protein activity through nanoencapsulation

    The United States of America as represented by the Secretary of the Army Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  8. US 6716410

    Reagents and methods for diagnosing, imaging and treating atherosclerotic disease

    The Regents of the University of California Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  9. US 6717017

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  10. US 6716825

    Phosphonate compounds

    The Regents of the University of California Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  11. US 6716423

    Recombinant neospora antigens and their uses

    The Regents of the University of California Β· Granted Apr 6, 2004 Β· Expires Apr 1, 2024

    expired
  12. US 6713078

    Retrocyclins: antiviral and antimicrobial peptides

    The Regents of the University of California Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  13. US 6713446

    Formulation of boronic acid compounds

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  14. US 6713284

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  15. US 6713301

    Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens

    United Biomedical, Inc. Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  16. US 6713081

    Ocular therapeutic agent delivery devices and methods for making and using such devices

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  17. US 6713095

    Product and process for stabilizing aloe vera gel

    Aloe Vera of America, Inc. Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  18. US 6713062

    Acinetobacter outer membrane protein and gene sequence compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  19. US 6713066

    Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  20. US 6713772

    Free-form fabrication using multi-photon excitation

    UNIVERSITY OF CONNECTICUT Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  21. US 6713507

    Ether compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  22. US 6713478

    Cyclocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  23. US 6713444

    Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins

    The United States of America as represented by the Secretary of the Army Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired
  24. US 6713056

    Combined preparation for the treatment of neoplasic diseases or of infectious diseases

    I.D.M. Immuno-Designed Molecules Β· Granted Mar 30, 2004 Β· Expires Mar 25, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.